Study at the Karolinska Institute suggests potential for reducing the high death rate from sepsis, one of the top-10 … (Business Wire via Yahoo! Finance)
February 9th, 2010 by admin
BERKELEY, Calif.—-ExThera Medical announced today that the results of a preliminary study of its proprietary medical device, Seraph™ extracorporeal affinity therapy, have been published in the current issue of the Journal of the American Society for Artificial Organs .
This entry was posted
on Tuesday, February 9th, 2010 at 8:12 am and is filed under Nano Medicine.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.